Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 93 for “"Thalidomide"”.
-
Thalidomide Metabolism and Metabolites
Thalidomide, renowned for causing birth defects in the late 1950s when used for the relief of morning sickness, has attracted new interest for the treatment of inflammatory conditions such as erythema nodosum leprosum and human malignancies such as multiple myeloma. Different species have different …
-
Relationship of Thalidomide Pharmacokinetics and Anti-Cancer Activity
There is a renewed interest in thalidomide as an anticancer agent. Considerable controversy exists in the literature as to its mechanism of action and whether the Rand S-enantiomers have similar activities. In the first part of this thesis, racemic nonracemisable analogues, 3-fluorothalidomide and …
-
Molecular Mechanisms and Determinants of Species Sensitivity in Thalidomide Teratogenesis
The expanding therapeutic use of thalidomide (TD) remains limited by its species-specific teratogenicity in humans and rabbits, but not rodents. The R and S isomers of TD may be selectively responsible for its respective therapeutic and teratogenic effects, but rapid in vivo racemization makes this …
-
Synthesis of Thalidomide Analogues and Their Potential in Cancer Treatment
Thalidomide has been used as an effective treatment for multiple myeloma. It is suggested that thalidomide exert its effects via immunomodulation and anti-angiogenesis. Many thalidomide analogues have been developed in order to reduce its adverse effect of teratogenicity and to improve its efficacy …
-
Thalidomide-induced teratogenesis in gray short-tailed opossums (Monodelphis domestica)
From 1957 to 1962, Thalidomide was prescribed to pregnant women as an antiemetic and was later discovered to cause serious birth defects. Thalidomide is currently being prescribed to treat erythema nodosum leprosum and multiple melanoma, and is being considered for other anti-angiogenic …
-
Life After the Scandal: Thalidomide, Family, and Rehabilitation in Modern Canada, 1958-1990
In the late 1950s and early 1960s, the drug thalidomide was prescribed to pregnant women around the world as a sedative to combat morning sickness. Instead of being "completely safe," as advertisements had promised, thalidomide caused "deformities" in children born to mothers who took the drug. In …
-
Percutaneous delivery of thalidomide and its N-alkyl analogues for treatment of rheumatoid arthritis
… fluid and synovial tissue (Saxne et al., 1989). Thalidomide is a proven inhibitor of the biological synthesis of TNF-a (Sampaio et al., 1991) and is believed to rely on this action for its suppression of the wasting of tissue which accompanies RA. Oral administration of thalidomide has proven to …
-
Ageing Differently: the health and independence of UK Thalidomide Survivors as they grow older
Background - In the late 1950s/early 1960s Thalidomide was given to thousands of pregnant women across the world to relieve morning sickness. The drug caused severe birth defects including missing/short limbs and sensory impairments, collectively referred to as Thalidomide Embryopathy (TE). …
-
A study of the anti-inflammatory, anti-microbial and immunomodulatory properties of thalidomide in leprosy
… leprosum (ENL) or reversal reaction (RR). Thalidomide is effective treatment for ENL, but not for RR. Using concentrations of thalidomide similar to that achieved in the treatment of ENL, we investigated thalidomide’s effect on reactions, viability of M. leprae, and integrity of plasma …
-
Pharmacokinetic and pharmacodynamic mechanisms for reduced toxicity of CPT-11 by thalidomide and St John's wort
… Clinical studies indicated that combination with thalidomide or St. Johna??s wort (SJW) alleviated CPT-11 induced toxicity. However, the underlying mechanisms involved are not fully understood. In this thesis, a rat model with dose-limiting toxicity profiles that are similar to those observed in …
-
Συστηματική φλεγμονώδης αντίδραση σε πειραματικό μοντέλο πολυτραυματία: η θέση της θαλιδομίδης
… production of TNFα require another approach. Thalidomide (a-N-phthalimidoglutarimide) was initially used as a sedative and antiemetic during pregnancy but it was withdrawn from the market due to its teratogenic effects. It is an immunomodulatory compound that selectively inhibits TNFα …
-
Investigating biomarkers in clinical samples that are predictive of response in multiple myeloma
… both genotypically and phenotypically. Thalidomide is an effective treatment for multiple myeloma. However, some patients fail to respond to thalidomide treatment and identifying this cohort may provide better individualized treatment. Proteomic analysis was performed on serum samples …
-
UNRAVELLING THE MOLECULAR MECHANISMS OF IMPAIRED LIMB DEVELOPMENT: ROLE OF DNP63A IN SPLIT-HAND/FOOT MALFORMATION TYPE 4 AND IN THALIDOMIDE TERATOGENICITY
… pathway promoted by the teratogenic drug thalidomide that leads to proteasome-mediated degradation of ΔNp63α, resulting in a lack of activation of ΔNp63α development-related target genes. In cell lines, thalidomide treatment induces a downregulation of ΔNp63α protein via the action of GSK3 …
-
Matrix degrading enzymes in IBD : dependence on TNFa and identification of IgG plasma cells as a novel source of MMP-3
… and the source of MMP-3 in IBD tissues.</p> <p>Thalidomide is an immunomodulatory drug that inhibits TNFα production by peripheral blood mononuclear cells (PBMC) and has been used in the treatment of resistant CD. However its mode of action is unknown and its clinical effectiveness remains …
-
Understanding the prognosis and progression of soft tissue sarcoma in the dog : a thesis presented in partial fulfilment of the requirements for the degree of Doctor of Philosophy at Massey University, Manawatū, New Zealand
… with many characteristics similar to STS – with thalidomide. Thalidomide is a potent antagonist of VEGF, but also has a number of other modulating influences on the tumour microenvironment. Dogs treated with thalidomide survived significantly longer than dogs that did not receive this drug, …
-
Recent studies on the reactions and synthesis of nitrogen and sulfur - containing heterocyclic pharmacophores.
… the phthalimide and glutarimide rings present in thalidomide. Thalidomide, a potent small-molecule therapeutic agent, precipitated a significant global drug crisis due to its teratogenicity, causing congenital malformations in phocomelia infants, which remains unrivaled over half a century ago. …
Page 1 of 5